<DOC>
	<DOCNO>NCT00142909</DOCNO>
	<brief_summary>Lofexidine experimental medication may beneficial reduce opiate withdrawal symptom , sleep difficulty , anxiety , tension . The purpose study determine whether lofexidine combination naltrexone improve individual 's ability cope stress subsequently increase chance remain abstinent opiate .</brief_summary>
	<brief_title>Effectiveness Lofexidine Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1</brief_title>
	<detailed_description>Naltrexone medication currently use treat opiate dependence . Naltrexone block euphoric effect opiate . However , naltrexone treatment suffers high rate drop-out relapse . One possible explanation opiate addict continue experience stress early recovery opiate dependence . Lofexidine experimental medication currently use United Kingdom opiate detoxification treat opiate withdrawal symptom , include sleep difficulty , muscle pain , anxiety , tension . The purpose study examine whether lofexidine combination naltrexone improve individual 's ability cope stress . The study examine whether , turn , increase likelihood individual remain abstinent opiate maintain recovery long time period . Participants 12-week , double-blind , placebo-controlled trial randomly assign receive either lofexidine placebo currently receive standard naltrexone outpatient treatment . Lofexidine initiated twice daily dos 0.4 mg increase 0.8 mg end Week 1 . The dos increase 1.2 mg end Week 2 , maintain level Weeks 3 12 . During Week 12 , lofexidine discontinuation taper 4 day . Hour-long study visit occur 3 time week assess vital sign , medication side effect , withdrawal symptom . Blood , alcohol , urine test perform well psychiatric evaluation . Administration naltrexone also occur 3 time week . Follow-up visit occur Months 1 3 discontinuation lofexidine .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Lofexidine</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<criteria>Meets DSMIV criterion opioid dependence Eligible take daily dose 50 mg naltrexone Normal EKG Able read English Currently psychotic psychiatrically disable ( e.g. , suicidal , homicidal , manic ) Regular use anticonvulsant , sedatives/hypnotics , prescription analgesic , antihypertensive ( include clonidine ) , antiarrhythmic , antiretroviral medication , tricyclic antidepressant Underlying medical condition , cerebral , kidney , thyroid , cardiac pathology , currently take medication condition Abstinent opiates 4 week prior initiation naltrexone Medical problem preclude naltrexone treatment , hepatocellular injury , evidence abnormal liver enzyme test ( great three time normal level ) history cirrhosis Hypotensive ( rest blood pressure 90/50 mm Hg ) Pregnant breastfeeding Use investigational drug within 3 month prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Opioid dependence</keyword>
</DOC>